Status: current, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4590934014 | Remogliflozin etabonate | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4590935010 | Remogliflozin etabonate (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Remogliflozin etabonate | Is a | Carbohydrate derivative | true | Inferred relationship | Some | ||
| Remogliflozin etabonate | Is a | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some | ||
| Remogliflozin etabonate | Has disposition | Sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Remogliflozin etabonate-containing product | Has active ingredient | True | Remogliflozin etabonate | Inferred relationship | Some | 1 |
| Remogliflozin etabonate only product | Has active ingredient | True | Remogliflozin etabonate | Inferred relationship | Some | 1 |
| Remogliflozin etabonate only product in oral dose form | Has active ingredient | True | Remogliflozin etabonate | Inferred relationship | Some | 1 |
| Remogliflozin etabonate-containing product in oral dose form | Has active ingredient | True | Remogliflozin etabonate | Inferred relationship | Some | 1 |
| Remogliflozin etabonate 100 mg oral tablet | Has precise active ingredient | True | Remogliflozin etabonate | Inferred relationship | Some | 1 |
| Remogliflozin etabonate 100 mg oral tablet | Has BoSS | True | Remogliflozin etabonate | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR